Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifuroxazide in Hepatic Encephalopathy
NCT05754996Phase 3Completed
- Sponsor
- Cairo University
- Start
- Mar 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuroxazide in hepatic encephalopathy (HE), sponsored by Cairo University. Started Mar 2023; status: completed.
02
Drugs
nifuroxazide
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT05754996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05754996.